Literature DB >> 2984621

Malignant mixed mesodermal tumor of the ovary: a report of 22 cases.

M Dictor.   

Abstract

Clinicopathologic data are presented for 22 cases of malignant mixed mesodermal tumors of the ovary of both homologous and heterologous types. The results substantiate previous reports of low parity in the almost exclusively postmenopausal women with this tumor. Symptoms were the same as for ovarian malignancy in general. More than half the patients presented with stage III or IV disease, according to the International Federation of Gynecology and Obstetrics (FIGO) classification. Only four (19%) of 21 patients were alive at 18 months and had survived from three to more than 13 years. Their survival was associated strictly with stage I or II disease and with the purely homologous stromal pattern. Two tumors were contiguous with remnants of ovarian endometriosis. Differentiated malignant epithelium was most often of the serous/endometrioid type, frequently with squamous zones, and was of the mucinous type in only one case. Whereas spindle cell stroma was present in many tumors of both stromal types, atypical cartilage was the predominant heterologous element.

Entities:  

Mesh:

Year:  1985        PMID: 2984621

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  8 in total

1.  Histogenesis of ovarian malignant mixed mesodermal tumours.

Authors:  T J Clarke
Journal:  J Clin Pathol       Date:  1990-04       Impact factor: 3.411

2.  Malignant mixed müllerian tumor of primary peritoneal origin.

Authors:  Margaux Kanis; Joshua P Kesterson; Stuti Shroff; Shashikant Lele; Paulette Mhawech-Fauceglia
Journal:  Ann Diagn Pathol       Date:  2010-06-20       Impact factor: 2.090

3.  Establishment and characterization of the NEYS cell line derived from carcinosarcoma of human ovary with special reference to the susceptibility test of anticancer drugs.

Authors:  Yoshiaki Ide; Taka Nakahara; Masanori Nasu; Noriko Tominaga; Akihiro Ohyama; Toshiaki Tachibana; Makoto Yasuda
Journal:  Hum Cell       Date:  2009-06-23       Impact factor: 4.174

4.  Prolonged survival of a patient with pelvic recurrence of ovarian malignant mixed mullerian tumor after chemoradiotherapy.

Authors:  Fatemeh Homaei Shandiz; Sima Kadkhodayan; Malihe Hsanzade Mofrad; Zohre Yousefi Roodsari; Noorieh Sharifi Sistani; Majid Nabizadeh Marvast; Mahbobe Sadeghei
Journal:  Iran Red Crescent Med J       Date:  2014-09-05       Impact factor: 0.611

5.  Endometriosis Malignant Transformation Review: Rhabdomyosarcoma Arising From an Endometrioma.

Authors:  Camran Nezhat; Mailinh Vu; Nataliya Vang; Kristen Ganjoo; Amer Karam; Ann Folkins; Azadeh Nezhat; Farr Nezhat
Journal:  JSLS       Date:  2019 Oct-Dec       Impact factor: 2.172

6.  Ovarian carcinosarcoma is a distinct form of ovarian cancer with poorer survival compared to tubo-ovarian high-grade serous carcinoma.

Authors:  Robert L Hollis; Ian Croy; Michael Churchman; Clare Bartos; Tzyvia Rye; Charlie Gourley; C Simon Herrington
Journal:  Br J Cancer       Date:  2022-06-17       Impact factor: 9.075

7.  Response to pembrolizumab in a heavily treated patient with metastatic ovarian carcinosarcoma.

Authors:  Graziela Zibetti Dal Molin; Carina Meira Abrahão; Robert L Coleman; Fernando Cotait Maluf
Journal:  Gynecol Oncol Res Pract       Date:  2018-08-18

8.  Primitive ovarian carcinosarcoma: a clinical and radiological analysis of five cases.

Authors:  Qiong Xu; Xiaofei Zhang; Yu Zou
Journal:  J Ovarian Res       Date:  2020-10-28       Impact factor: 4.234

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.